News on genetics and genomics applications in the Ag-Bio, Veterinary, Forensics, Food Safety, and Environmental Testing markets.
BioMérieux Gets CE Mark for Next-Gen Immunoassay System
The system runs the company's line of Vidas tests for emergency and critical care, immunochemistry, infectious diseases, and food industry pathogens.
Applied DNA Prices $12M Public Stock, Warrant Offering
The company, which develops molecular diagnostics and manufactures DNA, closed a roughly $4.2 million registered direct stock offering earlier this year.
BioMérieux Posts 1 Percent Drop in Q1 Revenues
BioMérieux said that it was unable to fulfill a backlog of orders for its BioFire respiratory panels during the quarter due to impact of COVID-19 on its workforce.
The firm's panel test, which will initially cost $400, identifies genetic biomarkers linked to over 20 cancers in dogs using cell-free and genomic DNA from blood.
PathSensors Gets Expanded License to MIT Pathogen Detection Technology
The expanded license from MIT includes clinical applications for the technology, with PathSensors initially targeting SARS-CoV-2 detection.